<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02646202</url>
  </required_header>
  <id_info>
    <org_study_id>Scleroligation</org_study_id>
    <nct_id>NCT02646202</nct_id>
  </id_info>
  <brief_title>Scleroligation for Eradication of Gastroesophageal Varices.</brief_title>
  <official_title>Scleroligation is a Safe and Effective New Technique for Eradication of Gastroesophageal Varices.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sherief Abd-Elsalam</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastric varices occur in 5-33% of patients with portal hypertension. Concomitant gastro
      esophageal varices are the most common type. Both endoscopic sclerotherapy and band ligation
      are very effective in controlling acute esophageal varices bleeding and preventing
      rebleeding.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of a new scleroligation technique for management of bleeding gastro-esophageal
      varices regarding efficacy, complications, variceal recurrence, and survival.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of sessions to complete variceal obliteration</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Gastroesophageal Varices</condition>
  <arm_group>
    <arm_group_label>Sclerotherapy group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>thirty patients treated by sclerotherapy for OV using ethanolamine oleate 5%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endoscopic band ligation group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>thirty patients treated by endoscopic banding using the Euro-Ligator system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sclero-ligation (SL) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>thirty patients treated by intra variceal endoscopic sclerotherapy combined with band ligation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sclerotherapy</intervention_name>
    <description>Injection of varices</description>
    <arm_group_label>Sclerotherapy group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Band ligation</intervention_name>
    <description>endoscopic banding of varices</description>
    <arm_group_label>Endoscopic band ligation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Scleroligation</intervention_name>
    <description>intra variceal endoscopic sclerotherapy combined with band ligation.</description>
    <arm_group_label>Sclero-ligation (SL) group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  cirrhotic patients presenting with an acute or recent episode of gastro-esophageal
             variceal bleeding.

        Exclusion Criteria:

          -  Patients were excluded if they had malignancy of any origin.

          -  Any terminal illness, such as heart failure, uremia, or chronic pulmonary diseases.

          -  Other potential causes of GIT bleeding.

          -  Patients with previous endoscopic or surgical intervention for varices were also
             excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ferial El-kalla, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of endoscopy unit - Tropical medicine department- Tanta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Elhendawy, Consultant</last_name>
    <role>Principal Investigator</role>
    <affiliation>liver diseases dept.- Tanta university hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Loai Mansour, Consultant</last_name>
    <role>Study Director</role>
    <affiliation>liver diseases dept.-Tanta university hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abdelrahman kobtan, Consultant</last_name>
    <role>Study Chair</role>
    <affiliation>liver diseases dept.-Tanta university hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rehab Badawy, Consultant</last_name>
    <role>Study Chair</role>
    <affiliation>liver diseases dept.-Tanta university hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hanan Elbasat, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>liver diseases dept.-Tanta university hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sherief Abd-Elsalam, Consultant</last_name>
    <role>Study Chair</role>
    <affiliation>Liver diseases and gastroenterology dept.-Tanta university hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sherief M. Abd-Elsalam, Consultant</last_name>
    <phone>00201095159522</phone>
    <email>sherif_tropical@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tropical medicine dept.-Tanta university hospital</name>
      <address>
        <city>Tanta</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherief Abd-Elsalam</last_name>
      <email>Sherif_tropical@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 1, 2016</study_first_submitted>
  <study_first_submitted_qc>January 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2016</study_first_posted>
  <last_update_submitted>December 22, 2017</last_update_submitted>
  <last_update_submitted_qc>December 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Sherief Abd-Elsalam</investigator_full_name>
    <investigator_title>Consultant liver and GIT diseases- Tanta university hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
    <mesh_term>Esophageal and Gastric Varices</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

